Indica Labs

Will you be at #ASCO26? Connect with Indica Labs’ VP of Precision Medicine, Doug Bowman, to discuss the evolving role of AI-powered digital pathology in companion diagnostic development. Together with our partners at Leica Biosystems, we are transforming the future of precision medicine through comprehensive and seamless CDx co-development, helping partners move from tissue insight to actionable precision medicine strategies with greater confidence.

If you're looking to jumpstart your antibody drug conjugate CDx project with more accurate, reproducible, and information-rich biomarker analysis data, Indica Labs has the expertise and tools to make it happen. Our team has been developing AI algorithms for oncology and immuno-oncology across a variety of imaging modalities, tissue types, and application areas since our founding in 2011, providing unbiased quantitative biomarker expression and spatial data that drive ADC development.

Indica Labs is advancing companion diagnostics with new initiatives in precision medicine, AI-driven products, and strategic regulatory workflows. For a deep dive into Indica Labs’ roadmap to CDx success, check out our recent webinar presented by Steven Hashagen, CEO and Founder; Peter Caie, Sr. Director, Precision Medicine; and Doug Bowman, VP Precision Medicine (moderator). Viewers can expect the following: - Learn about initiatives and strategies for developing AI-powered CDx products in digital pathology - Gain insight into our strategic partnership with Leica Biosystems - Understand the pathway to regulatory approved CDx

Together with our partners at Leica Biosystems, we offer end-to-end companion diagnostics development that combines our deep AI and biomarker analysis expertise with Leica Biosystems' vast portfolio of healthcare solutions and deep commercialization experience. From preclinical and proof of concept, to clinical trials and verification & validation, we have the experience and expertise for every step of your CDx journey.

❓What does a successful digital pathology cloud deployment look like in practice? The University of Washington BRaIN Lab partnered with our Cloud Services team to optimize their HALO deployment on AWS, resulting in a 40% reduction in cloud costs in just four months while supporting 35 active users across a nationwide collaboration network. Read the case study to see how partnering with Indica Labs Cloud Services can help advance your research and save funds:

☁Thinking about moving your digital pathology infrastructure to the cloud? A well-designed cloud deployment doesn’t just reduce on-prem IT burden, it can improve performance, scalability, collaboration, and data accessibility across your organization. Our Cloud Services team works with labs to design, deploy, and manage cloud environments of our industry leading HALO platforms. Read our introductory blog post to learn what a HALO cloud deployment can look like for your organization: